0001209191-14-017959.txt : 20140306 0001209191-14-017959.hdr.sgml : 20140306 20140306174238 ACCESSION NUMBER: 0001209191-14-017959 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140306 FILED AS OF DATE: 20140306 DATE AS OF CHANGE: 20140306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 BUSINESS PHONE: 604-629-9223 MAIL ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVITT DANIEL J CENTRAL INDEX KEY: 0001278711 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 14674308 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORP STREET 2: 2929 SEVENTH ST STE 100 CITY: BERKELEY STATE: CA ZIP: 94710 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-03-06 0 0001404644 AQUINOX PHARMACEUTICALS, INC AQXP 0001278711 LEVITT DANIEL J 50 PARKER AVENUE SAN FRANCISCO CA 94118 1 0 0 0 Stock Option (Right to Buy) 10.56 2018-07-01 Common Stock 3906 D Stock Option (Right to Buy) 5.76 2021-05-23 Common Stock 3906 D Stock Option (Right to Buy) 5.76 2023-05-29 Common Stock 3906 D The option securities subject to this option shall vest and become exercisable at a rate of one-third of the option securities underlying the options on the one-year anniversary of the vesting commencement date and 1/36th of the option securities underlying the options shall vest each monthly anniversary of the grant date thereafter for so long as the recipient of the option provides continuous service to the issuer, such that the total option securities underlying the options shall be fully vested on the three-year anniversary of the vesting commencement date. Each option granted under the issuer's Joint Canadian Stock Option Plan is exercisable for one "option security." Prior to the closing of the issuer's initial public offering, an option security is comprised of one common exchangeable share and one special voting share of Aquinox Pharmaceuticals Inc., a corporation under the Canadian Business Corporations Act. Following the closing of the issuer's initial public offering, an option security will be comprised of one share of the issuer's common stock. /s/Daniel Levitt 2014-03-06